A

AGIO

AGIO

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
AGIO Live QuoteReal-time
$29.68
$6.96(-19.00%)1M
Day Range$29.22 – $30.48
Open$29.57
Previous Close$29.89
Volume600.1K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.78B
P/E Ratio (TTM)24.5
Forward P/E2.5
EPS (TTM)$-6.31
Price to Book1.8
Dividend Yield0.65%
Beta (Volatility)0.62
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $29.68 (32%)
Low: $23.00High: $44.09
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$46.11-69.3% upside

Insider Buys

0

$0

Insider Sales

53

$10.88M

Total Volume

$10.88M

53 transactions

Net Activity

$10.88M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
G
1

Goff Brian

CEO

0 buys6 sells

$3.19M total

G
2

Gheuens Sarah

Chief Medical Officer

0 buys13 sells

$2.53M total

B
3

Burns James William

GC

0 buys6 sells

$1.72M total

B
4

Ballal Rahul D.

Dir

0 buys1 sells

$1.12M total

W
5

Washburn Theodore James Jr.

Principal Accounting Officer

0 buys5 sells

$648K total

Trading History
AGIO insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 21, 2026

4 weeks ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell2.0K$37.53$75K

Aug 4, 2026

3 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell30.0K$30.48$914K

Jul 1, 2026

4 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell4.0K$37.56$151K

Apr 2, 2026

7 months ago

Burns James William

GC

General Counsel
Sell3.3K$34.71$114K

Apr 2, 2026

7 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell2.9K$34.71$102K

Apr 2, 2026

7 months ago

Jones Cecilia

CFO

CFO
Sell3.1K$34.71$109K

Apr 2, 2026

7 months ago

Milanova Tsveta

Chief Commercial Officer

C-Level
Sell3.3K$34.71$113K

Apr 2, 2026

7 months ago

Viswanadhan Krishnan

Chief Corp Dev, Strategy

C-Level
Sell3.0K$34.71$103K

Apr 2, 2026

7 months ago

Goff Brian

CEO

CEO
Sell19.1K$34.71$662K

Mar 5, 2026

8 months ago

Viswanadhan Krishnan

Chief Corp Dev, Strategy

C-Level
Sell3.0K$27.80$82K

Mar 3, 2026

8 months ago

Washburn Theodore James Jr.

Principal Accounting Officer

C-Level
Sell5.3K$28.88$152K

Mar 2, 2026

8 months ago

Goff Brian

CEO

CEO
Sell18.1K$28.96$523K

Mar 2, 2026

8 months ago

Burns James William

GC

General Counsel
Sell5.2K$28.96$151K

Mar 2, 2026

8 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell4.1K$28.96$117K

Mar 2, 2026

8 months ago

Jones Cecilia

CFO

CFO
Sell5.0K$28.96$146K

Mar 2, 2026

8 months ago

Milanova Tsveta

Chief Commercial Officer

C-Level
Sell2.9K$28.96$83K

Jan 5, 2026

10 months ago

Milanova Tsveta

Chief Commercial Officer

C-Level
Sell2.9K$27.02$78K

Dec 30, 2025

10 months ago

Burns James William

GC

General Counsel
Sell2.9K$27.09$79K

Dec 30, 2025

10 months ago

Goff Brian

CEO

CEO
Sell18.7K$27.09$507K

Dec 30, 2025

10 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell2.9K$27.09$79K

Dec 30, 2025

10 months ago

Milanova Tsveta

Chief Commercial Officer

C-Level
Sell2.9K$27.09$79K

Dec 30, 2025

10 months ago

Jones Cecilia

CFO

CFO
Sell2.9K$27.09$79K

Nov 12, 2025

12 months ago

Scadden David

Dir

Director
Sell200$43.84$9K

Nov 11, 2025

12 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell2.5K$43.78$107K

Oct 30, 2025

12 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell200$43.81$9K

Oct 27, 2025

12 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell3.3K$43.92$145K

Oct 8, 2025

13 months ago

Scadden David

Dir

Director
Sell200$41.00$8K

Sep 30, 2025

13 months ago

Scadden David

Dir

Director
Sell200$40.00$8K

Sep 26, 2025

13 months ago

Jones Cecilia

CFO

CFO
Sell3.7K$36.77$134K

Sep 5, 2025

14 months ago

Washburn Theodore James Jr.

Principal Accounting Officer

C-Level
Sell8.5K$36.87$315K

Aug 27, 2025

14 months ago

Scadden David

Dir

Director
Sell200$40.00$8K

Aug 8, 2025

15 months ago

Goff Brian

CEO

CEO
Sell11.1K$36.67$406K

Jul 10, 2025

16 months ago

Scadden David

Dir

Director
Sell1.4K$40.00$56K

Jul 9, 2025

16 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell11.9K$37.99$453K

Jul 1, 2025

16 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell4.1K$34.17$140K

Jun 24, 2025

17 months ago

Burns James William

GC

General Counsel
Sell2.8K$33.54$94K

Jun 24, 2025

17 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell2.9K$33.54$98K

Jun 24, 2025

17 months ago

Jones Cecilia

CFO

CFO
Sell1.8K$33.54$60K

Jun 24, 2025

17 months ago

Milanova Tsveta

Chief Commercial Officer

C-Level
Sell2.8K$33.54$93K

Jun 24, 2025

17 months ago

Goff Brian

CEO

CEO
Sell18.7K$33.54$627K

Apr 10, 2025

19 months ago

Fouse Jacqualyn A

Dir

Director
Sell7.5K$25.90$194K

Mar 3, 2025

20 months ago

Burns James William

GC

General Counsel
Sell4.0K$35.54$142K

Mar 3, 2025

20 months ago

Jones Cecilia

CFO

CFO
Sell2.3K$35.54$81K

Mar 3, 2025

20 months ago

Milanova Tsveta

Chief Commercial Officer

C-Level
Sell1.7K$35.54$60K

Mar 3, 2025

20 months ago

Goff Brian

CEO

CEO
Sell12.9K$35.54$460K

Mar 3, 2025

20 months ago

Gheuens Sarah

Chief Medical Officer

C-Level
Sell4.0K$35.54$142K

Mar 3, 2025

20 months ago

Washburn Theodore James Jr.

Principal Accounting Officer

C-Level
Sell1.7K$35.54$59K

Feb 5, 2025

21 months ago

Washburn Theodore James Jr.

Principal Accounting Officer

C-Level
Sell2.3K$34.39$78K

Jan 6, 2025

22 months ago

Milanova Tsveta

Chief Commercial Officer

C-Level
Sell2.8K$32.18$90K

Dec 11, 2024

23 months ago

Scadden David

Dir

Director
Sell200$46.28$9K

Nov 8, 2024

24 months ago

Washburn Theodore James Jr.

Principal Accounting Officer

C-Level
Sell772$56.09$43K

Nov 7, 2024

24 months ago

Ballal Rahul D.

Dir

Director
Sell20.0K$55.86$1.12M

Nov 7, 2024

24 months ago

Burns James William

GC

General Counsel
Sell21.8K$52.21$1.14M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
AGIO Buy Conviction0%
Industry Rank#0 of 563
Volume Contribution0.1%
Total Industry Activity$16.73B

AGIO has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for AGIO

Over the last 90 days, corporate insiders at AGIO (AGIO) engaged in a total of 53 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 53 were sales. The total volume of insider trading reached $10.88M.

The net insider activity for AGIO shows a net selling bias of $10.88M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Burns James William (GC), who traded 21.8K shares valued at $1.14M on Nov 7, 2024.

Live Market News & Developments
Aggregated real-time headlines for AGIO (AGIO)
6 updates

Agios Pharmaceuticals (AGIO) Stock Looks Pricey Despite Its 39% Run

Yahoo Finance12d ago

AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know

TradingView44d ago

Agios falls on review extension for Pyrukynd label expansion

Seeking Alpha20d ago

AGIO - Agios Pharmaceuticals Inc Stock Price and Quote

Finviz176d ago

Agios Pharmaceuticals (AGIO) Stock Looks Fully Priced Against Current Sales

Yahoo Finance41d ago

Agios Pharmaceuticals Stock (AGIO) Opinions on Trading Strategies | AGIO Stock News

Quiver Quantitative62d ago

FAQs About AGIO Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for AGIO.

Based on SEC Form 4 disclosures, the Insider Confidence Score for AGIO is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 53 sales by company executives over the last 90 days.

The CEO Conviction Index for AGIO is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.